Header-1
Header-2
Header-3

Blood Test for Cancer

The ONCOblot® Test is a highly sensitive blood test for cancer. It confirms the presence of cancer as well as the tissue of origin through the detection of ENOX2 proteins.

Non-Invasive Option for Cancer Presence

The ONCOblot® Test is being used to confirm cancer presence.  The ONCOblot® Test provides a non-invasive next step to existing tests such as a High PSA, Abnormal Mammogram, Suspicious PET Scan and biopsies.  The test is being used to identify cancer of unknown primary (CUP), for recurrence monitoring, post cancer treatments and for targeted high risk populations.

Cancer Confirmation Test

Cancer Testing with Confidence

The ENOX2 protein species in the blood is unique to malignant cells and absent from non-cancer cells.  These proteins can be detected in early development.  The ONCOblot® Test identifies the ENOX2 markers and the direct visualization of a marker presence significantly reduces false positives.

Dr. James Morré and Dr. David Taggart speak to the history and future of the ONCOblot® test.

In the News

Read the Published Peer-Reviewed Study, January 2016:  “ENOX2 proteins from malignant mesothelioma are detected 4-10 years in advance of clinical symptoms.”

Reveals origin of malignant cells:

The ONCOblot® Test reveals the tissue of origin of the ENOX2 protein. The ONCOblot® database contains
the following 25+ cancers:

• Bladder
• Breast
• Cervical
• Colorectal
• Endometrial
• Esophageal
• Gastric
• Hepatocellular
• Kidney

• Leukemia
• Non-Small cell
• Lung Small cell
• Lymphoma
• Melanoma
• Mesothelioma
• Myeloma
• Ovarian

• Pancreatic
• Prostate
• Sarcoma
• Squamous Cell
• Follicular Thyroid
• Papillary Thyroid
• Testicular Germ Cell
• Uterine

Watch our 3 minute video for an overview of ENOX2 and how ONCOblot® works.

Upcoming Events

Click here for information regarding events ONCOblot has attended.
And, the Research Award presented to Drs. Morre’ at the AMMG, May 15, 2016!